Attitude and knowledge towards prescription of generic drugs: online study across Telangana
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20203622Keywords:
Attitude score, Generic drugs, Knowledge score, Online study, TelanganaAbstract
Background: Generic drugs are similar in terms of strength, safety and therapeutic benefit as compared to innovator counterparts. Generics have a favourable financial profile and a positive effect on medication adherence. Palpable change was not observed with the use of generics. This study has been designed to gauge the knowledge and attitude concerning generic drugs among medical students in their 5th semester of MBBS course and interns in the final six months of their compulsory rotatory residential internship (CRRI) program in the state of Telangana.
Methods: It was a cross sectional, online-questionnaire based study across medical colleges in Telangana. The questions were designed with the help of Google forms and the website links were circulated to the participants through students and interns’ whatsapp groups.
Results: 95.1% of interns and 92.7% of students had knowledge of generic drugs. Significant number of students had a notion that brand drugs are for serious illnesses. Majority in both the groups maintained a neutral opinion when it came to mandatory prescribing of generics.
Conclusions: Our study revealed a similar knowledge level about generic in both the groups and 40.9% of interns and 41.4% of students had a knowledge score of more than or equal to 80. Interns didn’t agree with incentivisation of brand drugs. 37.9% of interns and 32.3% of students had an attitude score of more than or equal to 80. Therefore implementation of certain practices like stocking of more generics at medical college pharmacies, more research and incentivisation of generic use can translate into a rise of generic usage.
Metrics
References
World Health Organization (WHO). Generic drugs. Geneva: WHO; 2015. http://www.who.int/trade/ glossary/story034/en/index.html. Accessed 21 June 2015.
Kefalas CH, Ciociola AA. The FDA’s generic-drug approval process: similarities to and differences from brand name drugs. Am J Gastroenterol. 2011;106:1018-21.
Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013;14:1.
Revised checklist for BA/BE NOC effective from 01st February 2014. Cdsco.nic.in. Available from: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadAlertsFiles/BABwebsite%202014reviseddocumentrequired.pdf. Accessed on 12 April 2018.
Medical Council of India: Circular on Generic Medicine. 2017. Available from: https://old.mciindia. org/circulars/Public-Notice-Generic-Drugs-21.04.2017.pdf. Accessed on 5 June 2017.
Approved drug products with therapeutic equivalence evaluations (Orange Book) Available from: https://www.fda.gov/drugs/informationondrugs/ucm129662.htm. Accessed on 15 October 2018.
Deb A, Dhavalshankh AG, Burande MA, Patil SS, Tahashildar JC. Evaluation of knowledge, attitude and perception about generic medicines among medical students and interns in a tertiary care hospital. J Adv Med Dent Sci Res. 2017;5(11):8-12.
Gyawali S, Hassali MA, Saha A. A survey exploring the knowledge and perceptions of senior medical students in Nepal toward generic medicines. SAGE Open Med. 2016;4:2050312116662570.
Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open. 2015;5(12).
Toklu HZ, Dülger GA, Hıdıroğlu S, Akici A, Yetim A, Gannemoğlu HM, Güneş H. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul-Turkey. Pharm Pract. 2012;10(4):199-206.
Joshi SS, Shetty YC, Karande S. Generic drugs- the Indian scenario. J Postgrad Med. 2019;65(2):67-9.
Downloads
Published
How to Cite
Issue
Section
